Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 00:51:03 - browse：342

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： HIV vaccine remains elusive. Immunologists keep trying new ideas

explore

leisure time

WSS

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

6 surprising facts about sugar

Case highlights the risks of experimental stem cell therapy

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Pregnancy ages women, but effects reverse after delivery

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout LOUD podcast: Live from STAT Breakthrough Summit West

ChatGPT in medicine: STAT answers readers' burning questions

Readout LOUD podcast, live from the STAT Breakthrough Summit East

In Memoriam: Notable people who died in 2023

Medicare Advantage insurers pressure Biden for bigger payments

Hollywood unions extend contract negotiations for actors

Diabetes management: Digital health tools fall short, study says

DIEP, the 'gold standard' of breast reconstruction, is under threat

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

focus

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

This gene therapy has record $4.25 million price. It's saved children.

Helping hospitals and community health centers plan for resilience

Second House panel advances two

NVIDIA and Google execs on the future of AI and drug discovery

Second House panel advances two

explore

explore

leisure time

explore